DNA Biomed Solns (DNA) — Working Capital to Net Assets Ratio
DNA Biomed Solns (DNA) has a Working Capital to Net Assets ratio of 70.3% as of June 2025. Working capital of ILA69.02 Million (current assets of ILA70.47 Million minus current liabilities of ILA1.44 Million) is measured against net assets of ILA98.23 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See DNA equity financing ratio to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
DNA Biomed Solns Working Capital to Net Assets (2013–2024)
This chart shows how DNA Biomed Solns's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2013 to 2024. As of June 2025, the ratio stands at 70.3%, reflecting working capital of ILA69.02 Million against net assets of ILA98.23 Million ILA. Check DNA Biomed Solns (DNA) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for DNA Biomed Solns (2013–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for DNA Biomed Solns from 2013 to 2024, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see DNA market cap.
| Year | WC/NA Ratio | Working Capital (ILA) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 66.3% | ILA67.30 Million | ILA101.47 Million | ILA68.43 Million | ILA1.13 Million | ▼ -17.3 pp |
| 2023 | 83.7% | ILA66.26 Million | ILA79.19 Million | ILA66.94 Million | ILA685.00K | ▲ +2.4 pp |
| 2022 | 81.3% | ILA65.14 Million | ILA80.11 Million | ILA65.93 Million | ILA789.00K | ▲ +37.8 pp |
| 2021 | 43.5% | ILA23.63 Million | ILA54.33 Million | ILA23.91 Million | ILA287.00K | ▲ +175.1 pp |
| 2020 | -131.6% | ILA-10.46 Million | ILA7.95 Million | ILA80.00K | ILA10.54 Million | ▼ -112.6 pp |
| 2019 | -19.0% | ILA-5.35 Million | ILA28.18 Million | ILA3.20 Million | ILA8.55 Million | ▲ +4.6 pp |
| 2018 | -23.6% | ILA-15.30 Million | ILA64.90 Million | ILA515.00K | ILA15.81 Million | ▼ -12.9 pp |
| 2017 | -10.7% | ILA-7.38 Million | ILA69.11 Million | ILA1.60 Million | ILA8.99 Million | ▼ -33.4 pp |
| 2016 | 22.7% | ILA-18.95 Million | ILA-83.41 Million | ILA21.93 Million | ILA40.88 Million | ▲ +105.1 pp |
| 2015 | -82.4% | ILA6.88 Million | ILA-8.35 Million | ILA11.44 Million | ILA4.56 Million | ▼ -91.7 pp |
| 2014 | 9.2% | ILA-773.00K | ILA-8.36 Million | ILA2.84 Million | ILA3.62 Million | ▼ -23.7 pp |
| 2013 | 32.9% | ILA3.78 Million | ILA11.49 Million | ILA6.64 Million | ILA2.86 Million | — |